109221 ⎘
Applications; Uses Special therapeutic applications
RNA with a combination of unmodified and modified nucleotides for protein expression
#1202METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TUMORIGENICITY
#1203ANTISENSE DESIGN
#1204ANTISENSE DESIGN
#1205Delivery of therapeutic agent
#1206Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)
#1207Methods and compositions using miR-3151 in the diagnosis and treatment of thyroid cancer
#1208Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
#1209CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS
#1210Modulation of axon degeneration
#1211Use of aptamers in therapy and/or diagnosis of autoimmune diseases
#1212COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING MUSCULAR DYSTROPHY
#1213Polynucleotides for multivalent RNA interference, compositions and methods of use thereof
#1214Formulations comprising antisense nucleotides to connexins
#1215PROCESSES FOR PRODUCING EXOSOMES IN REDUCED OXYGEN CULTURE CONDITIONS
#1216PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS
#1217Corneal endothelium ECM therapeutic medicaments
#1218Detection and treatment of irritable bowel syndrome
#1219Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor
#1220Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#1221METHOD OF INHIBITING BINDING OR ACTIVITY OF MIF BY ADMINISTERING A MIF ANTAGONIST
#1222Low density lipoprotein receptor-mediated siRNA delivery
#1223Compositions and methods for treating alzheimer's disease and other tauopathies
#1224TMPRSS6 iRNA compositions and methods of use thereof
#1225RNA interference-based therapeutic against anthrax
#1226Compositions and methods for inhibiting expression of TMPRSS6 gene
#1227LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME
#1228RNAi agent for inhibition of Chikungunya virus
#1229MULTIVALENT APTAMER COMPLEXES
#1230Inhibition of microRNA for treatment of sepsis
#1231AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTION
#1232Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof
#1233DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS
#1234Micro-RNA family that modulates fibrosis and uses thereof
#1235Micro-RNA family that modulates fibrosis and uses thereof
#1236Micro-RNA family that modulates fibrosis and uses thereof
#1237Compositions, kits and methods for treatment of cardiovascular,immunological and inflammatory diseases
#1238CHI3L1 FOR THE DETECTION AND TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
#1239Oncogene associated with human cancers and methods of use thereof
#1240Methods for detecting and treating multiple myeloma
#1241Antisense-oligonucleotides as inhibitors of TGF-R signaling
#1242TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH DYSREGULATION OF MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1 (MTORC1)
#1243COMPOSITIONS AND METHODS FOR THE TREATMENT OF VprBP-RELATED CANCERS
#1244Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#1245Microrna and uses in brown fat differentiation
#1246Antisense oligonucleotides for treatment of cancer stem cells
#1247Methods and compositions for the diagnosis and treatment of cancer
#1248METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT
#1249Preventive or therapeutic agent for fibrosis
#1250APTAMERS FOR THE TREATMENT OF SICKLE CELL DISEASE
#1251OLIGONUCLEOTIDE MODULATORS OF B-CELL CLL/LYMPHOMA 11A (BCL11A) AND USES THEREOF
#1252Methods for maturing cardiomyocytes and uses thereof
#1253KIR3DL2 IS A BIOMARKER AND A THERAPEUTIC TARGET USEFUL FOR RESPECTIVELY PREVENTING AND TREATING A SUBSET OF CUTANEOUS AND NON-CUTANEOUS PERIPHERAL T-CELL LYMPHOMAS
#1254Oligonucleotide analogues incorporating 5-aza-cytosine therein
#1255Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 Isoforms
#1256METHOD OF SCREENING FOR CHAPERONIN MODULATOR
#1257QSOX1 AS AN ANTI-NEOPLASTIC DRUG TARGET
#1258RESPIRATORY DISEASE-RELATED GENE SPECIFIC SIRNA, DOUBLE-HELICAL OLIGO RNA STRUCTURE CONTAINING SIRNA, COMPOSITON CONTAINING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE
#1259COMPOSITIONS AND METHODS FOR MODULATION OF TARGET NUCLEIC ACIDS
#1260PROTEIN INVOLVED IN DNA REPLICATION, AND MODULATION OF ITS ACTIVITY
#1261Molecules of the card-related protein family and uses thereof
#1262Methods for identifying agents useful for modulating the expression and aggregation of CAG-expanded gene product in cells
#1263Inhibition of MAP4K4 through RNAi
#1264SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERING RNA
#1265PROSTATE CANCER-SPECIFIC ALTERATIONS IN ERG GENE EXPRESSION AND DETECTION AND TREATMENT METHODS BASED ON THOSE ALTERATIONS
#1266Methods and compositions for the treatment of cancer
#1267Predictive biomarker for cancer therapy
#1268Compositions and methods for inhibiting expression of the ALAS1 gene
#1269Treatment of insulin resistance through inhibitors of transcription factor TSC22D4
#1270Methods for diagnosing and treating learning or mental disorders
#1271Complement component C5 iRNA compositions and methods of use thereof
#1272Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression
#1273Modulation of HSP47 expression
#1274Hydrophobically modified antisense oligonucleotides comprising a ketal group
#1275Targeting microRNAs for the treatment of fibrosis
#1276OLIGOMERS TARGETING HEXANUCLEOTIDE REPEAT EXPANSION IN HUMAN C9ORF72 GENE
#1277Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification
#1278Methods and compositions for templated assembly of nucleic acid specific heterocompounds
#1279NEUROTENSIN-INDUCED TUMOR FORMATION IS REGULATED BY MICRO RNA 133A-AFTIPHILIN-DEPENDENT RECEPTOR RECYCLING
#1280IN VIVO PRODUCTION OF SMALL INTERFERING RNAS THAT MEDIATE GENE SILENCING
#1281CROSSLINKED ANTI-HIV-1 COMPOSITIONS FOR POTENT AND BROAD NEUTRALIZATION
#1282Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders
#1283QSOX1 as an anti-neoplastic drug target
#1284SDF-1 binding nucleic acids and the use thereof in cancer treatment
#1285Methods and compositions for treatment of a genetic condition
#1286Methods to prevent and treat autosomal dominant non-syndromic hearing loss
#1287Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)
#1288Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism
#1289METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES
#1290Compositions and methods for treating cancer
#1291Phase changing formulations of nucleic acid payloads
#1292Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease
#1293METHODS, COMPOSITIONS AND KITS FOR PROMOTING MOTOR NEURON SURVIVAL AND TREATING AND DIAGNOSING NEURODEGENERATIVE DISORDERS
#1294Pharmaceutical composition for treating liver diseases
#1295siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#1296Hydrazinyl lipidoids and uses thereof
#1297Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells
#1298Modulation of androgen receptor expression
#1299Cancer treatment methods using remote conditioning
#1300BIOACTIVE APOLAR EXTRACT CONTAINING PLANT GENETIC MATERIAL FOR TREATMENT OF MAMMALIAN DISEASES
#1301Treatment of inflammatory diseases
#1302Compositions and Methods for Evaluating Heart Failure
#1303MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION
#1304Huntington's disease therapeutic compounds
#1305Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
#1306Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
#1307Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
#1308Composition for controlling stem cells pluripotency, containing LIN28A methylation inhibitor, and method for screening for LIN28A methylation inhibitor
#1309Method for assaying microRNA, cancer therapeutic agent, and medicinal composition containing same for cancer therapy
#1310COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN
#1311METHOD OF TREATMENT OR PROPHYLAXIS INFTAMMATORY PAIN
#1312METHODS AND COMPOSITIONS FOR IMPROVING SLEEP AND MEMORY
#1313B7-H4 EXPRESSION ON TUMOR VASCULATURE
#1314Structure and use of 5′ phosphate oligonucleotides
#1315METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1
#1316Viral and viral associated miRNAs and uses thereof
#1317Targeting chromatin modifiers for the treatment of medical conditions
#1318Modulation of hepatitis B virus (HBV) expression
#1319Aptamer to IL-17 and use thereof
#1320Interferon production using short RNA duplexes
#13215′ modified nucleosides and oligomeric compounds prepared therefrom
#1322HSA-MIR-146B-5P-related nucleic acids and uses thereof
#1323Methods for enhancing utrophin production via inhibition of microRNA
#1324Method for inhibiting proliferation of high LIX1L-expressing tumor cell, and tumor cell proliferation-inhibiting peptide
#1325Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
#1326METHOD FOR THE DIAGNOSIS, PROGNOSIS, AND TRATMENT OF CANCER METASTASIS
#1327Mutations in DSTYK cause dominant urinary tract malformations
#1328Compositions and methods for in vivo excision of HIV-1 proviral DNA
#1329FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITION FOR THE TREATMENT OF DISEASE
#1330Biological Materials and Uses Thereof
#1331Biomarkers associated with BRM inhibition
#1332CD7 receptor aptamers
#1333Oral delivery of therapeutically effective LNA oligonucleotides
#1334Method of deriving mature hepatocytes from human embryonic stem cells
#1335STRAIN OF DEFORMED WING VIRUS (DWV)
#1336METHODS AND PHARMACEUTICALS COMPOSITIONS FOR TREATING BREAST CANCERS
#1337Therapeutic agent for fibroid lung
#1338Methods and compositions related to T-cell activity
#1339Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules
#1340TREATING TH2-MEDIATED DISEASES BY INHIBITION OF BROMODOMAINS
#1341Methods for including cardiomyocyte proliferation
#1342Compositions And Methods For Inhibiting Expression Of GSK-3 Genes
#1343LNA antisense oligonucleotides for the modulation of Myc expression
#1344Molecules inhibiting the human immunodeficiency virus type 1 (HIV-1), method for the production thereof and applications of same
#1345Targeting microRNA miR-409-3P to treat prostate cancer
#1346Serpinc1 iRNA compositions and methods of use thereof
#1347Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1348DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#1349PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS (PMOS) AND THEIR USE IN SUPPRESSION OF MUTANT HUNTINGTIN EXPRESSION AND ATTENUATION OF NEUROTOXICITY
#1350CHIMERIC OLIGOMERIC COMPOUNDS AND THEIR USE IN GENE MODULATION
#1351Methods and compositions for RNA-guided treatment of HIV infection
#1352PHF20 AND JMJD3 COMPOSITIONS AND METHODS OF USE IN CANCER IMMUNOTHERAPY
#1353Oligomers and oligomer conjugates
#1354Organic compositions to treat EPAS1-related diseases
#1355Method for treating and/or preventing myopia
#1356OLIGOMERIC COMPOUNDS AND EXCIPIENTS
#1357Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1
#1358PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
#1359METHODS FOR REGULATING HAIR GROWTH DISORDERS
#1360Biodegradable lipids for the delivery of active agents
#1361Vectors and methods for genetic immunization
#1362BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#1363MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION
#1364Nanotubes as Carriers of Nucleic Acids into Cells
#1365Compositions And Methods To Enhance Protein Expression
#1366Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#1367RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
#1368Multiple exon skipping compositions for DMD
#1369Multiple exon skipping compositions for DMD
#1370Multiple exon skipping compositions for DMD
#1371Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#1372Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#1373Diagnostic and treatment for chronic and acute phase myeloid leukemia
#1374Nanoparticles stabilized with nitrophenylboronic acid compositions
#1375Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating such cancers
#1376Methods of diagnosing, treating and monitoring diabetic retinopathy
#1377Methods to identify and treat subjects having corticosteroid-resistant asthma
#1378Modified oligonucleotides for telomerase inhibition
#1379Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
#1380Influenza-activated constructs and methods of use thereof
#1381Aptamers that bind CD271
#1382Multiple exon skipping compositions for DMD
#1383Multiple exon skipping compositions for DMD
#1384Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#1385Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#1386Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations
#1387CCCTC-Binding Factor (CTCF) RNA Interactome
#1388Lipid formulations for delivery of therapeutic agents to solid tumors
#1389COMPOSITIONS AND METHODS OF INHIBITING GENE EXPRESSION IN A LUNG
#1390Compositions and methods for treating pancreatic cancer
#1391LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
#1392Methods to screen compounds for regulating USF1 activity and methods and compounds to treat cardiometabolic and lipid pathologies
#1393ShRNA molecules and methods of use thereof
#1394Aptamers for tumor initiating cells
#1395Intranuclear protein transduction through a nucleoside salvage pathway
#1396MODIFIED SMALL INTERFERING RNA MOLECULES AND METHODS OF USE
#1397Methods for treating eye disorders
#1398Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
#1399T cell balance gene expression, compositions of matters and methods of use thereof
#1400Methods of modulating GABAergic inhibitory synapse formation and function
#1401ANTIGENE OLIGOMERS INHIBIT TRANSCRIPTION
#1402Aptamer against midkine and applications thereof
#1403Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#1404Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#1405Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof
#1406Methods and compositions involving miRNA and miRNA inhibitor molecules
#1407Vectors and methods for genetic immunization
#1408Oligonucleotides for modulation of target RNA activity
#1409Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
#1410Modulation of Insulin Like Growth Factor I Receptor Expression in Cancer
#1411Methods and compositions involving miRNA and miRNA inhibitor molecules
#1412Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
#1413Methods of trans-differentiating a terminally differentiated target cell to a neuron
#1414Cationic lipid
#1415Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms
#1416FURTHER USE OF PROTEIN KINASE N BETA
#1417RNA TARGETED TO C-MET
#1418Phosphoribosyl pyrophosphate synthetase 2 (PRPS2) as a therapeutic target in cancer treatment
#1419Oligonucleotide compositions and methods of making the same
#1420MUCOSAL HEALING PROMOTER
#1421Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#1422Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA Molecules
#1423Aptamer for periostin and anti-cancer composition including same
#1424Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1425DESIGN OF OLIGONUCLEOTIDE ANALOGS AS THERAPEUTIC AGENTS
#1426LONG NON-CODING RNA USED FOR ANTICANCER THERAPY
#1427IDENTIFICATION AND USE OF NEW TUMOR-PROMOTING GENE IN HEMATOLOGICAL MALIGNANCIES
#1428Systems and methods for diagnosing and treating cancer
#1429SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTATIS
#1430Modified oligonucleotides for telomerase inhibition
#1431Modified oligonucleotides for telomerase inhibition
#1432SNPs OF APOLIPOPROTEIN B AND MODULATION OF THEIR EXPRESSION
#1433Cancer treatment and immune system regulation through FAT10 pathway inhibition
#1434Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy
#1435Methods and compositions for detection of targets for autoimmune disease
#1436Antisense modulation of PTP1B expression
#1437HEPATITIS C DSRNA EFFECTOR MOLECULES, EXPRESSION CONSTRUCTS, COMPOSITIONS, AND METHODS OF USE
#1438Methods of inhibiting cancer stem cells with HMGA1 inhibitors
#1439Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers
#1440Compositions and methods for silencing apolipoprotein C-III expression
#1441Method for inhibiting calcification of a macrophage-derived matrix vesicle
#1442Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
#1443RNA preparations comprising purified modified RNA for reprogramming cells
#1444Method of rapidly inducing large-scale and high-purity mesenchymal stem cells to transdetermine into hematopoietic stem cells
#1445Disulfide masked prodrug compositions and methods
#1446Nutlin-3A for treatment of proliferative vitreoretinopathy
#1447Methods for diagnosing and treating prostate cancer
#1448Compositions and methods for modulation of FGFR3 expression
#1449Aptamers, multimeric aptamers and uses thereof
#1450Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof
#1451Modulation of Hematopoietic Stem Cell Differentiation
#1452Inhibitory oligonucleotide and use thereof
#1453CD133 aptamers for detection of cancer stem cells
#1454CIRCULAR RNA FOR INHIBITION OF MICRORNA
#1455Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#1456METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#1457LOW-DENSITY LIPOPROTEIN ANALOGUE NANOPARTICLES, AND COMPOSITION COMPRISING SAME FOR TARGETED DIAGNOSIS AND TREATMENT OF LIVER
#1458Methods and Compositions for treatment of cancer by inhibition of NR2F2
#1459Inhibition of histone methyltransferase for cardiac reprogramming
#1460Extraction, preparation, and application of plant micro-ribonucleic acid
#1461Methods of treating kennedy's disease
#1462METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1463METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1464Therapeutics with conformationally restricted monomers
#1465Oligonucleotide complex compositions and methods of use as gene alteration tools
#1466Poly(vinyl ester) polymers for in vivo nucleic acid delivery
#1467Polymeric nanoparticles
#1468Inhibiting migration of cancer cells
#1469COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY
#1470Compositions and methods for regulating arterial tone
#1471Methods for the diagnosis and treatment of sjögren's syndrome
#1472Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#1473METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS
#1474Oligomeric compounds comprising bicyclic nucleosides and uses thereof
#1475Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof
#1476Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation
#1477Composition and methods for the prevention and treatment of diet-induced obesity
#1478UGT8 mini-promoters
#1479NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
#1480Nanotubes as carriers of nucleic acids into cells
#1481Nanocarriers and their processing for diagnostics and therapeutics
#1482Use of miR-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects
#1483Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
#1484USE OF ATX INHIBITORS FOR TREATMENT OR PREVENTION OF INFLUENZA VIRUS A INFECTIONS
#1485Targets in multiple myeloma and other disorders
#1486METHODS AND COMPOSITIONS FOR MODIFYING THE IMMUNE RESPONSE
#1487MULTIMERIC OLIGONUCLEOTIDE COMPOUNDS
#1488LYVE-1 ANTAGONISTS FOR PREVENTING OR TREATING A PATHOLOGICAL CONDITION ASSOCIATED WITH LYMPHANGIOGENESIS
#1489THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE
#1490Methods for producing a population of pancreatic beta-cells
#1491Methods and compositions for treating cancer
#1492Euchromatic region targeting methods for modulating gene expression
#1493TELOMERASE INHIBITORS FOR USE IN THERAPY
#1494Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#1495SDF-1 binding nucleic acids
#1496Glucagon Binding Nucleic Acids
#1497Compositions and methods for treatment of prostate and other cancers
#1498RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#1499PHARMACEUTICAL COMPOSITION FOR TREATING LIVER DISEASES
#1500Antisense polynucleotides to induce exon skipping and methods of treating dystrophies